Abstract
Joint ventures between tax-exempt hospitals and for-profit organizations have become a common mechanism for hospitals to acquire new sources of revenue and expand health care services without relying solely on traditional funding. However, these partnerships can lead to unfavorable tax consequences if not structured according to Internal Revenue Service (IRS) regulations. IRS Revenue Ruling 2004-51 established that an exempt organization maintains its status as long as it contributes only an "insubstantial" amount of its assets or activities to a venture. Yet, the ruling failed to define the threshold at which activities become "substantial." This paper examines the current uncertainty regarding these definitions and argues that participation in an ancillary joint venture should not be considered substantial unless it markedly restricts the furtherance of a hospital's charitable purposes.
Introduction
Tax-exempt hospitals increasingly utilize "ancillary joint ventures" with for-profit entities to fund specialized facilities, such as MRI centers or ambulatory surgical units. While these collaborations expand healthcare access and provide necessary capital, they exist within a regulatory "gray zone." If the IRS deems a hospital’s involvement in these ventures to be a "substantial" portion of its overall activities, the hospital risks the catastrophic loss of its 501(c)(3) tax-exempt status.
The core challenge lies in the ambiguity of IRS Revenue Ruling 2004-51. While the ruling permits such ventures if they represent an "insubstantial" part of the organization’s activities, it provides no quantitative or qualitative definition of that term. This leaves hospital administrators and legal counsel in a position of guesswork, unsure if a single project—or the cumulative effect of several small projects—will trigger a loss of exemption.
The Evolution of IRS Oversight
Historically, the IRS focused primarily on the element of "control." In foundational cases such as Redlands Surgical Services and St. David’s Health Care System, the central question was whether the non-profit entity maintained operational or board-level control over the venture to ensure it served a charitable purpose.
Revenue Ruling 2004-51 shifted the regulatory goalposts. It suggested that even in instances where a hospital lacks control over a joint venture, the venture is "safe" as long as it remains an insubstantial part of the hospital's total activities. This shift introduced a new, undefined variable into the compliance equation: scale.
The Ambiguity of "Substantiality"
The lack of a clear definition for substantiality has led to several misconceptions and risks within the healthcare sector:
- The "Safe Harbor" Myth: Many practitioners rely on a 5% "rule of thumb" borrowed from lobbying law to define insubstantiality. However, the IRS has never officially adopted this percentage for joint ventures. Furthermore, courts in other tax contexts have found activities representing as little as 16% of an organization's resources to be "substantial."
- The Aggregation Trap: While a single ancillary venture might be considered insubstantial in isolation, the IRS may aggregate multiple ventures. Without a clear threshold, hospitals may unknowingly cross the line into "substantial" territory through a "death by a thousand cuts" scenario.
- Control as a Failsafe: Analysis of recent Private Letter Rulings (such as PLR 200610022) suggests that control remains a vital fallback. If an activity is deemed substantial, the organization may still preserve its status if it retains total operational or editorial control, ensuring the activity remains tethered to its charitable mission.
Proposed Framework: A Functional Approach
To resolve this uncertainty, this paper proposes a shift toward a "Commensurate in Scope" test, borrowing from existing Unrelated Business Income Tax (UBIT) regulations.
Rather than a rigid, numerical asset-percentage test, the IRS should adopt a functional standard. Participation in an ancillary joint venture should only be considered substantial if it "markedly restricts" the hospital's ability to provide public benefit. Specifically, the author suggests that as long as a hospital devotes at least 40-50% of its total resources to its core charitable mission, its participation in ancillary ventures should not threaten its tax-exempt status, regardless of whether it maintains direct control over those specific ventures.
Conclusion
The current regulatory environment forces tax-exempt hospitals to navigate significant financial expansions with inadequate guidance. By defining substantiality through the lens of whether a venture restricts the primary charitable mission—and by establishing a clear resource-based threshold—the IRS can provide the clarity necessary for hospitals to innovate without risking their fundamental tax status. Future administrative action should specifically address the aggregation of multiple ventures to provide a "bright-line" moment for when ancillary activities transition from helpful sidelines to disqualifying primary purposes.
Summary updated